Tag: TME
TME Pharma: positive results in brain tumors
(CercleFinance.com) – TME Pharma announced on Wednesday that a study had shown that 83% of patients with glioblastoma, a brain cancer, were still alive after 15 months of treatment, “unheard…
TME Pharma: Positive results in brain tumors
(CercleFinance.com) – TME Pharma announced on Wednesday that a study had shown that 83% of patients with glioblastoma, a brain cancer, were still alive after 15 months of treatment, “unheard…
TME Pharma: the FDA approves a clinical trial in the USA – 06/15/2023 at 18:20
(CercleFinance.com) – TME Pharma announces today that the US Food and Drug Administration (FDA) has approved its request to launch a new clinical trial aimed at evaluating its main asset,…
TME Pharma: the FDA accepts a new clinical trial for Nox-A12 – 06/15/2023 at 18:24
(AOF) – TME Pharma announces today that after a complete review of the dossier submitted to it, the American Food and Drug Administration (FDA) has approved the request to launch…
TME Pharma: the FDA approves a clinical trial in the USA
(CercleFinance.com) – TME Pharma announces today that the US Food and Drug Administration (FDA) has approved its request to launch a new clinical trial aimed at evaluating its main asset,…
TME PHARMA ANNOUNCES THE CONVENING OF THE ANNUAL GENERAL MEETING OF SHAREHOLDERS 2023 – 05/30/2023 at 08:00
Berlin, Germany, May 30, 2023, 08:00 CEST – TME Pharma NV (Euronext Growth Paris: ALTME), a biotechnology company specializing in the development of novel therapies for the treatment of cancer…
TME Pharma: cash of 4.6 million euros at the end of December, visibility until September 2023 – 04/18/2023 at 18:29
(AOF) – TME Pharma publishes cash of 4.6 million euros as of December 31, 2022, which gives it “financial visibility until September 2023” (unaudited figures). This biotechnology company specializing in…
TME PHARMA ANNOUNCES THE SUCCESSFUL FINANCING OF 2 MILLION EUROS AND THE END OF THE CONVERTIBLE BOND PROGRAM WITH BLOCKING OF NEW SHARES AND BLOCKING OF BOND CONVERSIONS EXTENDING ITS FINANCIAL VISIBILITY UNTIL DECEMBER 2023 – 04/18/ 2023 at 20:00
To receive all of the company’s financial communications in real time, please register directly by email at the following address: [email protected] TME Pharma NV (Euronext Growth Paris: ALTME), a biotechnology…
TME Pharma: CEO’s message is appreciated
(CercleFinance.com) – TME Pharma rose sharply on the Paris Stock Exchange on Friday following an optimistic message from the CEO of the biotechnology company, Aram Mangasarian. In a letter sent…
TME Pharma: The CEO’s message is appreciated
(CercleFinance.com) – TME Pharma rose sharply on the Paris Stock Exchange on Friday following an optimistic message from the CEO of the biotechnology company, Aram Mangasarian. In a letter sent…
TME Pharma: the CEO’s message is appreciated – 02/24/2023 at 16:02
(CercleFinance.com) – TME Pharma rose sharply on the Paris Stock Exchange on Friday following an optimistic message from the CEO of the biotechnology company, Aram Mangasarian. In a letter sent…
TME Pharma: Updated data in brain cancer
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…